AAA Pharmaceutical, Inc.
Form 483 issued March 28, 2025 · Lumberton, New Jersey
- Investigator
- Tanya R. Syffrard
- Observations
- 1
- Pages
- 3
- FEI number
- 3010027650
In short: On March 28, 2025, FDA issued a Form 483 with 1 observation to AAA Pharmaceutical, Inc. in Lumberton, New Jersey (FEI 3010027650). The investigator was Tanya R. Syffrard. Most observations concern laboratory controls; the most-cited regulation is 21 CFR 211.166 (stability testing).
At a glance
1 of 1 observations on this 483 concern laboratory controls.
Most cited: 21 CFR 211.166(a) (1×)
What FDA observed
Preview: the opening words of each observation- 01
The written stability testing…
This inspection in context
Tanya R. Syffrard
11 documents · 2021–2025
Cites 211.166 (stability testing) more than any other section. Most of their documents are for sites in New York.
The firmAAA Pharmaceutical, Inc. history
All 2 documents on file for this site, in date order, with what was cited at each inspection.
Similar 483sOther sites cited under 211.166(a)
See how FDA wrote the same problem up elsewhere.
Questions about this 483
What did FDA find at AAA Pharmaceutical, Inc.?
FDA listed 1 observation on this Form 483, mostly about laboratory controls. The most-cited regulation is 21 CFR 211.166 (stability testing). The opening words of each observation are shown on this page.
Who inspected AAA Pharmaceutical, Inc.?
Tanya R. Syffrard is named on this Form 483. Each investigator has a profile showing what they cite most.
When was AAA Pharmaceutical, Inc. inspected by FDA?
This Form 483 is dated March 28, 2025.
How do I get the full Form 483 for AAA Pharmaceutical, Inc.?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.